drugset / Trial / NCT05307341
Improving Pain Management and Decreasing LOS After Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA)
RandomizedParallel-groupSingle-blindTreatment
Summary
This two arm, patient blinded, randomized, post market clinical trial in a single orthopedic hospital will determine whether there is improved pain management and decreased length of stay when comparing standard of care pain management with and without sufentanil.
Timeline
- Start
- 2022-03
- Primary completion
- 2023-06
- Completion
- 2023-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sufentanil | Other / unclassified | 30 ug | Other |
Indications
No indication recorded.